Sztanek, F.;                     Tóth, L.I.;                     Pető, A.;                     Hernyák, M.;                     Diószegi, Á.;                     Harangi, M.    
        New Developments in Pharmacological Treatment of Obesity and Type 2 Diabetes—Beyond and within GLP-1 Receptor Agonists. Biomedicines 2024, 12, 1320.
    https://doi.org/10.3390/biomedicines12061320
    AMA Style
    
                                Sztanek F,                                 Tóth LI,                                 Pető A,                                 Hernyák M,                                 Diószegi Á,                                 Harangi M.        
                New Developments in Pharmacological Treatment of Obesity and Type 2 Diabetes—Beyond and within GLP-1 Receptor Agonists. Biomedicines. 2024; 12(6):1320.
        https://doi.org/10.3390/biomedicines12061320
    
    Chicago/Turabian Style
    
                                Sztanek, Ferenc,                                 László Imre Tóth,                                 Attila Pető,                                 Marcell Hernyák,                                 Ágnes Diószegi,                                 and Mariann Harangi.        
                2024. "New Developments in Pharmacological Treatment of Obesity and Type 2 Diabetes—Beyond and within GLP-1 Receptor Agonists" Biomedicines 12, no. 6: 1320.
        https://doi.org/10.3390/biomedicines12061320
    
    APA Style
    
                                Sztanek, F.,                                 Tóth, L. I.,                                 Pető, A.,                                 Hernyák, M.,                                 Diószegi, Á.,                                 & Harangi, M.        
        
        (2024). New Developments in Pharmacological Treatment of Obesity and Type 2 Diabetes—Beyond and within GLP-1 Receptor Agonists. Biomedicines, 12(6), 1320.
        https://doi.org/10.3390/biomedicines12061320